Influence of patients' living conditions on tuberculosis treatment outcomes in a South African health sub-district

S Afr Fam Pract (2004). 2020 Aug 25;62(1):e1-e6. doi: 10.4102/safp.v62i1.5036.

Abstract

Background: Tuberculosis (TB) remains a serious public health concern because it continues devastating communities. This survey was conducted in the sub-district 2 of the Tshwane health district, South Africa. It aimed at determining the influence of patients' living conditions on TB treatment outcomes. Human immunodeficiency virus (HIV) status, food security and exposure to cigarette smoke were considered as living conditions; and cure, death, default, failure and relapse were considered TB treatment outcomes.

Methods: Record review using the Aitahealth database, clinic registers as well as a piloted, structured and administered questionnaire.

Results: Convenience sampling applied; 180 respondents were obtained. Tuberculosis respondents with negative HIV status had a cure rate of 67.3% whilst those with positive HIV status had 37%. Tuberculosis respondents with good food security had 45.9% of cure rate. Tuberculosis respondents exposed to cigarette smoke had a death rate of 65.2%, while respondents not exposed to cigarette smoke showed 75% of cure rate.

Conclusion: HIV status, food security and exposure to cigarette smoke, as components of living conditions, showed an association with TB treatment outcomes in the selected sample; in the sense HIV infection reduced the cure rate, increased the death and default rates of TB patients in the same sample. Good food security increased the cure rate of TB patients, but exposure to cigarette smoke decreased the cure rate and increased the death rate amongst respondents having TB treatment in the current survey.

Keywords: South Africa; Tshwane health district; living conditions; public health; tuberculosis treatment outcomes.

MeSH terms

  • HIV Infections* / complications
  • Humans
  • Social Conditions
  • South Africa / epidemiology
  • Treatment Outcome
  • Tuberculosis* / drug therapy